Detalhe da pesquisa
1.
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.
Immunity
; 51(4): 735-749.e8, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563464
2.
A scalable and high yielding SARS-CoV-2 spike protein receptor binding domain production process.
Protein Expr Purif
; 205: 106241, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736512
3.
Development of a Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of SARS-CoV-2 Spike Glycoprotein and Nucleoprotein.
Anal Chem
; 92(20): 13813-13821, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966064
4.
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies.
Nature
; 499(7456): 102-6, 2013 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23698367
5.
Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897.
J Infect Dis
; 218(4): 572-580, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617879
6.
Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.
J Virol
; 91(16)2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592535
7.
Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
J Virol
; 91(8)2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28148790
8.
Structural and genetic basis for development of broadly neutralizing influenza antibodies.
Nature
; 489(7417): 566-70, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932267
9.
Production of native recombinant proteins using a novel split intein affinity technology.
J Chromatogr A
; 1724: 464908, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669943
10.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157856
11.
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques.
Vaccine
; 41(10): 1735-1742, 2023 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764908
12.
Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring.
Microbiol Spectr
; 10(5): e0103422, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993765
13.
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.
EBioMedicine
; 77: 103902, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228013
14.
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.
Sci Transl Med
; 14(635): eabl8124, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076282
15.
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.
Nat Microbiol
; 6(10): 1233-1244, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34548634
16.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Cell Rep
; 37(12): 110143, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919799
17.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
bioRxiv
; 2021 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013273
18.
A mammalian reductive deiodinase has broad power to dehalogenate chlorinated and brominated substrates.
J Am Chem Soc
; 131(40): 14212-3, 2009 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19777994
19.
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera.
Sci Rep
; 8(1): 8628, 2018 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29872070
20.
Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
PLoS One
; 12(11): e0188708, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29182682